Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Divi's Laboratories (DIVI IN)
Watchlist
125
Analysis
Health Care
•
India
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
01 Mar 2015 23:26
India's Budgets: 2006-2015. Key Charts, and Key questions
In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective: 2014 Actual...
Pawan Sachdeva
557 Views
Share
bullish
•
Thematic (Sector/Industry)
•
05 Feb 2015 16:01
Introducing Long Term Leaders - Focussed Insights for your Core Holdings
We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category, we have identified companies that...
Sumeet Singh
Follow
497 Views
Share
bullish
•
Aditya Birla Capital
•
30 Dec 2025 05:58
NIFTY200 Momentum30 Index Rebalance: Huge Turnover and Flow in December
The Nifty200 Momentum30 Index rebalances at the close today. On average, the adds have outperformed the deletes by 2.76% since announcement of the...
Brian Freitas
Follow
1.3k Views
Share
bullish
•
Aditya Birla Capital
•
03 Dec 2025 06:30
NIFTY200 Momentum30 Index Rebalance Preview: 64% One-Way Turnover & US$1.8bn Trade
We forecast 19 changes for the index in Dec. One-way turnover is estimated at 64.2% resulting in a round-trip trade of INR 163bn (US$1.8bn). The...
Brian Freitas
Follow
740 Views
Share
bearish
•
Canara HSBC Life Insurance
•
17 Oct 2025 10:05
Canara HSBC Life Insurance IPO Trading - Muted Demand All Round
Canara HSBC Life Insurance raised about US$284m from its India IPO. In this note, we will talk about the trading dynamics.
Akshat Shah
Follow
475 Views
Share
First
Previous
6
7
8
9
10
11
12
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x